Massachusetts Financial Services CO Emergent Bio Solutions Inc. Transaction History

Massachusetts Financial Services CO

$320 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$7.35 - $13.21 $4,659 - $8,375	-634 Reduced 2.3%	26,878 $197,000
Q1 2023 May 10, 2023	SELL	$7.79 - $16.29 $6,052 - $12,657	-777 Reduced 2.75%	27,512 $285,000
Q4 2022 Feb 13, 2023	BUY	$11.0 - $21.45 $6,578 - $12,827	598 Added 2.16%	28,289 $334,000
Q3 2022 Nov 09, 2022	SELL	$20.09 - $35.8 $5,062 - $9,021	-252 Reduced 0.9%	27,691 $581,000
Q2 2022 Aug 09, 2022	BUY	$27.42 - $43.63 $3,838 - $6,108	140 Added 0.5%	27,943 $867,000
Q1 2022 May 11, 2022	BUY	$36.48 - $52.22 $10,396 - $14,882	285 Added 1.04%	27,803 $1.14 Million
Q4 2021 Feb 10, 2022	SELL	$33.11 - $55.01 $18,475 - $30,695	-558 Reduced 1.99%	27,518 $1.2 Million
Q3 2021 Nov 10, 2021	SELL	$50.07 - $66.05 $18,475 - $24,372	-369 Reduced 1.3%	28,076 $1.41 Million
Q2 2021 Aug 13, 2021	BUY	$56.61 - $80.46 $13,756 - $19,551	243 Added 0.86%	28,445 $1.79 Million
Q1 2021 May 13, 2021	SELL	$86.23 - $125.19 $288,611 - $419,010	-3,347 Reduced 10.61%	28,202 $2.62 Million
Q4 2020 Feb 12, 2021	BUY	$79.17 - $111.47 $538,039 - $757,550	6,796 Added 27.46%	31,549 $2.83 Million
Q3 2020 Nov 12, 2020	BUY	$81.91 - $134.94 $68,558 - $112,944	837 Added 3.5%	24,753 $2.56 Million
Q2 2020 Aug 11, 2020	SELL	$54.33 - $89.52 $33,249 - $54,786	-612 Reduced 2.5%	23,916 $1.89 Million
Q1 2020 May 14, 2020	BUY	$49.34 - $68.76 $1.21 Million - $1.69 Million	24,528 New	24,528 $1.42 Million
Q4 2018 Feb 08, 2019	SELL	$55.63 - $73.24 $1.78 Million - $2.34 Million	-31,970 Closed	0 $0
Q3 2018 Oct 25, 2018	SELL	$52.05 - $66.51 $3,851 - $4,921	-74 Reduced 0.23%	31,970 $2.11 Million
Q2 2018 Jul 30, 2018	BUY	$48.33 - $55.64 $212,072 - $244,148	4,388 Added 15.87%	32,044 $1.62 Million
Q1 2018 May 04, 2018	BUY	$44.44 - $54.39 $22,975 - $28,119	517 Added 1.91%	27,656 $1.46 Million
Q4 2017 Feb 14, 2018	BUY	$37.77 - $47.75 $167,396 - $211,628	4,432 Added 19.52%	27,139 $1.26 Million
Q3 2017 Nov 14, 2017	BUY	$34.14 - $40.45 $775,216 - $918,498	22,707	22,707 $918,000

Others Institutions Holding EBS

# of Institutions

160

Shares Held

33.8M

Call Options Held

453K

Put Options Held

931K

Black Rock Inc. New York, NY

3.84M
Shares

$32.3 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

3.4M
Shares

$28.6 Million
0.0% of portfolio
Marshall Wace, LLP London, X0

2.49M
Shares

$21 Million
0.03% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

2.22M
Shares

$18.7 Million
0.0% of portfolio
State Street Corp Boston, MA

1.91M
Shares

$16.1 Million
0.0% of portfolio

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $420M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.

Account